Statins have been reported to inhibit the expression of bFGF, HGF, and TGF-β in osteosarcoma cells through the inhibition of geranylgeranyl pyrophosphate (GGPP) biosynthesis in the mevalonate pathway. This evidence concerns the gene FGF2 and osteosarcoma.